1,389 Shares in Zoetis Inc. (NYSE:ZTS) Purchased by IFG Advisory LLC

IFG Advisory LLC acquired a new position in Zoetis Inc. (NYSE:ZTS) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,389 shares of the company’s stock, valued at approximately $241,000.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Zoetis by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 40,749,571 shares of the company’s stock valued at $6,895,235,000 after buying an additional 414,605 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Zoetis by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after buying an additional 3,244,074 shares during the period. Capital World Investors lifted its stake in Zoetis by 0.6% in the fourth quarter. Capital World Investors now owns 9,064,158 shares of the company’s stock worth $1,788,988,000 after acquiring an additional 57,798 shares during the period. Norges Bank bought a new position in Zoetis during the 4th quarter worth about $980,646,000. Finally, Bank of New York Mellon Corp raised its holdings in shares of Zoetis by 4.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 4,687,902 shares of the company’s stock valued at $812,695,000 after purchasing an additional 178,303 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

ZTS has been the topic of several research reports. Piper Sandler lifted their price objective on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. BTIG Research raised their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. The Goldman Sachs Group lowered their price target on shares of Zoetis from $223.00 to $196.00 and set a “buy” rating on the stock in a report on Monday, May 6th. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $200.00 price objective on shares of Zoetis in a report on Tuesday, August 27th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $217.11.

Zoetis Stock Up 0.3 %

Shares of ZTS stock opened at $183.49 on Tuesday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $201.92. The firm has a market capitalization of $83.13 billion, a PE ratio of 35.35, a P/E/G ratio of 2.81 and a beta of 0.88. The stock’s 50-day simple moving average is $180.06 and its 200-day simple moving average is $174.43.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The company had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. During the same period last year, the firm posted $1.41 EPS. Zoetis’s revenue for the quarter was up 8.3% compared to the same quarter last year. Equities analysts expect that Zoetis Inc. will post 5.84 earnings per share for the current year.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.